Working Group 5

Communication, Dissemination and Exploitation

wORKING GROUP 5

Communication, Dissemination and Exploitation

Working Group 5 is responsible for ensuring visibility, knowledge transfer, and stakeholder engagement across the CardioPharmaGENET network. The group manages communication channels, dissemination activities, and the overall outreach strategy of the project.

Dr. Theodora Katsila

National Hellenic Research Foundation

This includes the development of the project website, publication of scientific results, organization of events, and continuous engagement through social media and newsletters. WG5 also facilitates collaboration between researchers, clinicians, industry partners, and policymakers.

By making project outputs accessible and understandable to both expert and non-expert audiences, this working group maximizes the impact, sustainability, and long-term value of the initiative.